Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Integrative hair therapy improved hair loss and regrowth.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Crash dieting can cause temporary hair loss due to not getting enough energy for hair growth.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Hair growth and shedding involve specific cell changes and gene roles.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

The supplement significantly improves hair density and appearance in people with hair loss.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Telogen effluvium causes temporary hair loss, especially in women.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

A liquid protein diet caused hair loss in a young woman.

Dutasteride mesotherapy can cause hair loss in some people.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Patient history is key in diagnosing hair loss types.

Telogen effluvium is hair loss caused by many hairs stopping growth suddenly, often due to stress or illness, but sometimes it's normal and not due to disease.